Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank57
5Y CAGR-31.1%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-31.1%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$516000.00-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$3.33M+44.6%
2019$2.30M+78.1%
2018$1.29M-